Renewable Energy Stock Alert: Solar Wind Energy Tower, Inc. (SWET) Extends Rights to Develop Energy Downdraft Towers in Chile

ANNAPOLIS, MD - November 4, 2013 (Investorideas.com renewable energy stocks newswire) Solar Wind Energy Tower, Inc. (OTCQB: SWET) (the "Company"), the inventor of a large Solar Wind Downdraft Tower structure capable of producing abundant, inexpensive electricity, announced today that it has entered into a Memorandum of Understanding with Cobracrest Chile, SPA, which granted Cobracrest a "Negotiations Period" for rights to license trade secrets, patents, and knowledge from Solar Wind Energy. During the "Negotiations Period" Cobracrest has the exclusive right to "hold itself out in Copiapo and Caldera, Chile" and to enter into a long term "Definitive Agreement" with Solar Wind Energy to use the rights to develop Solar Wind Energy Downdraft Towers in Chile.

Under the "Definitive Agreement" Solar Wind Energy will provide technical support and personnel to advise and assist Cobracrest in project development, design, procurement, construction and the operation of a Tower Facility. Solar Wind Energy will also assist Cobracrest with the technical and feasibility studies as well as presentations necessary for proposals to the Government of Chile and the Ministry of Energy along with potential project participants. The Memorandum of Understanding outlines terms of the license fee for Copiapo and Caldera in Chile, as well as specific recurring royalties and fees for each Tower Facility within the territory.
Ronald Pickett, CEO, Solar Wind Energy Tower, Inc. commented: "We are pleased to have formed this relationship with Cobracrest. We have worked diligently for over three years assembling the team, techniques, and knowhow to enable this clean alternative energy solution to be brought to market. Our business plan has always been to enable developers to materialize projects across the globe where weather conditions are most suitable. These regions of Chile provide prime environments for the Tower, and the desire and need for power in Chile is extremely high."
About Solar Wind Energy, Inc.
Solar Wind Energy, Inc. ("Solar Wind Energy"), a wholly owned subsidiary of Solar Wind Energy Tower, Inc., was established to utilize proven and validated scientific principles, combining them with state of the art construction systems to enable the development and commercialization of large Solar Wind Downdraft Tower structures that produce abundant, inexpensive electricity. Our Company's core objective and focus is to become a leading enabler of clean, efficient green energy to the world communities, at a reasonable cost, without the destructive residuals of fossil fuels, while continuing to generate innovative technological solutions for tomorrow's electrical power needs. The Company intends to establish partnerships at home and abroad to propagate Tower Projects and meet the increasing global demand for electricity. The Company does not intend to own the projects. The business plan includes receiving license fees for territories, development fees during construction, and recurring royalty fees based on the actual kilowatt hours produced by the Tower. Solar Wind Energy has assembled a team of experienced business professionals, engineering and scientific consultants with the proven ability to bring this solution to market. Solar Wind Energy has filed and been issued patents that the Company believes will further enhance this potentially revolutionary technology. Solar Wind Energy, Inc., based in Annapolis, MD, is traded on the OTCQB under the symbol 'SWET'. For more information visit www.solarwindenergytower.com
Innovative Renewable Hybrid Solar / Wind Energy Technology
We view ourselves as a hybrid solar/wind technology, reflected in the name, Solar Wind Energy Tower, Inc. The simplicity of our solution is comprised of harnessing the natural power of a downdraft created within the confines of our Solar Wind Downdraft Tower structure, a hollow cylinder reaching skyward into the hot, dry atmosphere heated by the solar rays of the sun. The water introduced by the injection system near the top of the Tower evaporates and is absorbed by the hot, dry air. The air becomes cooler, denser and heavier than the outside warmer air and falls through the cylinder at speeds up to and in excess of 50 mph and is diverted into wind tunnels surrounding the base of the Tower where turbines inside the tunnels power generators to produce electricity.
Abundant, Clean, Affordable Electricity Production
The Company has successfully managed to economize the Tower, reducing capital costs and improving projected financial performance. This development was made possible by utilizing our recently announced software which can calculate and predict energy production by our Solar Wind Downdraft Towers given local weather data. By feeding the weather data into the program, the Tower's height and diameter can be adjusted along with the amount of water added as fuel to create a desired amount of energy. The outcome dictates the optimum size of the Tower's height and width.
Under the most recent design specifications, the first San Luis Tower has a design capacity on an hourly basis, of up to 1,250 megawatt hours, gross. Due to lower capacities during winter days, the average hourly output per day for sale to the grid for the entire year is approximately 435 megawatt hours.
Cautionary Note Regarding Forward-Looking Statements
Statements included in this release may constitute "forward-looking statements". Actual results may differ materially from those projected in forward-looking statements. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand and the Company's ability to obtain new contracts and accurately estimate revenues, if any, due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. Further information on potential factors that could affect the Company's financial results, can be found in the Company's various filings with the Securities and Exchange Commission (SEC).
Contact:
Solar Wind Energy, Inc.
1997 Annapolis Exchange Parkway
Suite 300
Annapolis, Maryland 21401
Phone: 410-972-4713
E-mail: Info@swetower.com
About InvestorIdeas.com:
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense renewable energy, food and beverage stocks and others.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for our news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and use our 14 online stock directories to research stocks - waters stocks, renewable energy, tech, mobile, mining stocks and more… http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Disclosure: Investorideas.com was paid five hundred dollars for this news release distribution
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
800-665-0411 - Source - www.Investorideas.com

Renewable Energy Stock Alert: Solar Wind Energy Tower, Inc. (SWET) Receives Energy Conversion Patent Allowance

ANNAPOLIS, MD - October 31, 2013 (Investorideas.com renewable energy stocks newswire) Solar Wind Energy Tower, Inc. (OTCQB: SWET) (the "Company"), the inventor of a large Solar Wind Downdraft Tower structure capable of producing abundant, inexpensive electricity, announced today it has been notified by US Patent Office of the Allowance of Patent Application # 13/027,409 which enhances and broadens previously issued Patent #8120191 covering the novel production of electric energy from traditional generators powered by a hydraulic pressure and drive system derived from multiple traditional wind turbines.

Ron Pickett, CEO, commented: "Our Company continues to protect by patent, trade secret, and proprietary information our solution to clean, affordable, alternative energy. Our business plan has always been to deliver this solution to developers, utilities, governments and sovereign nations and provide the team to produce the Tower. In exchange for enabling this solution, Solar Wind Energy's model is to receive license fees, development fees and recurring royalties based on the electricity produces by each project."
About Solar Wind Energy, Inc.
Solar Wind Energy, Inc. ("Solar Wind Energy"), a wholly owned subsidiary of Solar Wind Energy Tower, Inc., was established to utilize proven and validated scientific principles, combining them with state of the art construction systems to enable the development and commercialization of large Solar Wind Downdraft Tower structures that produce abundant, inexpensive electricity. Our Company's core objective and focus is to become a leading enabler of clean, efficient green energy to the world communities, at a reasonable cost, without the destructive residuals of fossil fuels, while continuing to generate innovative technological solutions for tomorrow's electrical power needs. The Company intends to establish partnerships at home and abroad to propagate Tower Projects and meet the increasing global demand for electricity. The Company does not intend to own the projects. The business plan includes receiving license fees for territories, development fees during construction, and recurring royalty fees based on the actual kilowatt hours produced by the Tower. Solar Wind Energy has assembled a team of experienced business professionals, engineering and scientific consultants with the proven ability to bring this solution to market. Solar Wind Energy has filed and been issued patents that the Company believes will further enhance this potentially revolutionary technology. Solar Wind Energy, Inc., based in Annapolis, MD, is traded on the OTCQB under the symbol 'SWET'. For more information visit www.solarwindenergytower.com
Innovative Renewable Hybrid Solar / Wind Energy Technology
We view ourselves as a hybrid solar/wind technology, reflected in the name, Solar Wind Energy Tower, Inc. The simplicity of our solution is comprised of harnessing the natural power of a downdraft created within the confines of our Solar Wind Downdraft Tower structure, a hollow cylinder reaching skyward into the hot, dry atmosphere heated by the solar rays of the sun. The water introduced by the injection system near the top of the Tower evaporates and is absorbed by the hot, dry air. The air becomes cooler, denser and heavier than the outside warmer air and falls through the cylinder at speeds up to and in excess of 50 mph and is diverted into wind tunnels surrounding the base of the Tower where turbines inside the tunnels power generators to produce electricity.
Abundant, Clean, Affordable Electricity Production
The Company has successfully managed to economize the Tower, reducing capital costs and improving projected financial performance. This development was made possible by utilizing our recently announced software which can calculate and predict energy production by our Solar Wind Downdraft Towers given local weather data. By feeding the weather data into the program, the Tower's height and diameter can be adjusted along with the amount of water added as fuel to create a desired amount of energy. The outcome dictates the optimum size of the Tower's height and width.
Under the most recent design specifications, the first San Luis Tower has a design capacity on an hourly basis, of up to 1,250 megawatt hours, gross. Due to lower capacities during winter days, the average hourly output per day for sale to the grid for the entire year is approximately 435 megawatt hours.
Cautionary Note Regarding Forward-Looking Statements
Statements included in this release may constitute "forward-looking statements". Actual results may differ materially from those projected in forward-looking statements. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand and the Company's ability to obtain new contracts and accurately estimate revenues, if any, due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. Further information on potential factors that could affect the Company's financial results, can be found in the Company's various filings with the Securities and Exchange Commission (SEC).
Contact:
Solar Wind Energy, Inc.
1997 Annapolis Exchange Parkway
Suite 300
Annapolis, Maryland 21401
Phone: 410-972-4713
E-mail: Info@swetower.com
About InvestorIdeas.com:
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense renewable energy, food and beverage stocks and others.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for our news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and use our 14 online stock directories to research stocks - waters stocks, renewable energy, tech, mobile, mining stocks and more… http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Disclosure: Investorideas.com was paid five hundred dollars for this news release distribution
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
800-665-0411 - Source - www.Investorideas.com

Renewable Energy Stock Alert: Solar Wind Energy Tower, Inc. (SWET) Closes up 13.57% on News

New York, NY, Point Roberts, WA - October 30, 2013 (Investorideas.com renewable energy stocks newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research for independent investors, reports on renewable energy stock Solar Wind Energy, Inc. (OTCQB: SWET). The stock closed trading on Tuesday up 13.5% on over 900,000 shares.

The company, the inventor of a large Solar Wind Downdraft Tower, reported that its Equity Facility to fund up to $3,000,000 from Beaufort Ventures, PLC is now effective and Solar Wind Energy may access the funds under the terms of the agreement.
Earlier this summer on July 15th, the Company announced it had received the commitment for the Equity Facility from Beaufort. Under the terms of the commitment, the Company was required to file an S-1 Registration Statement with the SEC. The Company was notified by the SEC that there were no further comments and the Registration Statement has now been declared "Effective" which allows the Company to access Equity Facility funding.
Tanvier Malik, Director of Beaufort Ventures, PLC commented: "Beaufort is pleased to play a role assisting Solar Wind Energy to bring its amazing clean alternative energy solution to the market. Beaufort Ventures looks to invest in Companies that have a viable business model where we can assist in both short term and long term goals. We have been familiar with the management of Solar Wind for many years and believe that this potentially "game changing" energy solution under the direction of this management truly has the potential to make a global impact."
Full news: http://finance.yahoo.com/news/solar-wind-energy-tower-inc-123000408.html
About Solar Wind Energy, Inc.
Solar Wind Energy, Inc. ("Solar Wind Energy"), a wholly owned subsidiary of Solar Wind Energy Tower, Inc., was established to utilize proven and validated scientific principles, combining them with state of the art construction systems to enable the development and commercialization of large Solar Wind Downdraft Tower structures that produce abundant, inexpensive electricity. Our Company's core objective and focus is to become a leading enabler of clean, efficient green energy to the world communities, at a reasonable cost, without the destructive residuals of fossil fuels, while continuing to generate innovative technological solutions for tomorrow's electrical power needs. The Company intends to establish partnerships at home and abroad to propagate Tower Projects and meet the increasing global demand for electricity. The Company does not intend to own the projects. The business plan includes receiving license fees for territories, development fees during construction, and recurring royalty fees based on the actual kilowatt hours produced by the Tower. Solar Wind Energy has assembled a team of experienced business professionals, engineering and scientific consultants with the proven ability to bring this solution to market. Solar Wind Energy has filed and been issued patents that the Company believes will further enhance this potentially revolutionary technology. Solar Wind Energy, Inc., based in Annapolis, MD, is traded on the OTCQB under the symbol 'SWET'. For more information visit www.solarwindenergytower.com
About InvestorIdeas.com:
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense renewable energy, food and beverage stocks and others.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for our news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and use our 14 online stock directories to research stocks - waters stocks, renewable energy, tech, mobile, mining stocks and more… http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Disclosure: Investorideas.com was paid five hundred dollars for this news release distribution
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
800-665-0411 - Source - www.Investorideas.com

Biometric Stock Alert: Nxt-ID, Inc. (OTCQB:NXTD) Announces Distribution Agreement With India's Voice of Big data (VOBD) for 3D FaceMatch™ Biometric Identification Systems

SHELTON, CT - October 29, 2013 (Investorideas.com biometrics/ defense stocks newswire) NXT-ID Inc. (OTCQB: NXTD) a biometrics company focused on the growing m-commerce market and its wholly owned subsidiary, 3D-ID, LLC, today announced an agreement with Indian/U.S.technology company, Voice of Big data (VOBD), to distribute its patented 3D FaceMatch™ biometric facial recognition identification systems in India.

3D FaceMatch™ will be added to Voice of Big data's current Facial Signature product line as part of its security and intelligence division. The technology will be targeted to retail markets, law enforcement, airports, government agencies, public and private organizations, product development centers and offshore development centers.
Voice of Big data reported to fytimes.com in August that it will be the first company in India to launch 3D facial recognition technology in India.
It was recently chosen as one of the top 10 promising technology startups in India by Nasscom's Emerge; (ET Times October 25th). The fast growing company has 65 employees comprising 20 data scientists and anticipates hiring 80 more by the end of the year.
Mr. Gino Pereira, Chief Executive Officer of NXT-ID, Inc., said, "Clearly, this is another milestone in our history as we continue to make solid progress as we implement our growth strategy. We are delighted to be partnering with VOBD in such an exciting developing market. India is at the forefront of the biometric revolution and with our combined expertise in 3D facial recognition and the ability to analyze large amounts of data very quickly I believe we can contribute substantially to biometric adoption here."
Srinivas Kishan Anapu, CEO of VOBD, reiterated that "the partnership with NXT-ID is a major strategic milestone for Voice of Big Data in the R&D space and for implementation of facial recognition solutions across industries globally. Additionally we see a huge value addition to our customers especially in India."
3D FaceMatch™ facial imaging solutions provide government, law enforcement and security agencies with fast, precise, automated and low-cost solutions for biometrically-accurate imaging of human faces in three dimensions. By acquiring the shape of a subject's face, together with a perfectly registered image, FaceMatch technology enables dramatic performance enhancements in human identification systems ranging from manual photo ID verification to automated facial recognition.
The global facial recognition market is estimated to grow from $1.92 billion in 2013 to $6.5 billion in 2018 according to a report earlier this year from http://www.marketsandmarkets.com/. Analysts forecast the biometrics market in India to cross USD 2 Billion revenues by 2018.
About Voice of Big data (VOBD)
Voice of Big data (VOBD) has its offices spread across US, UK, Australia and India. The company is incorporated with focus to provide sustainable BI solutions to clients. We have a highly dedicated team that constantly researches the trends in Bigdata, providing the most optimized solutions to the clients in BI space. At VOBD, Over 70% of Analytics is performed against Structured & Unstructured data. VOBD has invested in focused groups around tools & frameworks to provide client value-adds. This experience has helped VOBD build robust CoEs and reusable Frameworks for its customers. VOBD currently comprises of a Full time team of professionals from all domains and technologies related to Big data, BI and Analytics. VOBD has expertise across BFS, Insurance, Media, Manufacturing, Retail, Technology, Healthcare, Life Sciences and Utilities domains. http://voiceofbigdata.com
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms. NXT-ID' wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
Forward-Looking Statements for NXT-ID
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.
Contact:
Corporate info: info@nxt-id.com
Investor Relations
Kirin Smith
ProActive Capital Group
Direct: 646 863 6519
Published at the Investorideas.com Newswire - Big ideas for Global Investors
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: this release was compensated for by NXTD as part of a monthly service for news publication and distribution and content marketing. (five thousand per month plus 144 shares)
More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Mobile biometric security products and services is set to grow and will generate over $8.3 billion revenue by 2018

Biometrics Research; Goode Intelligence forecasts that the market for mobile biometric security products and services is set to grow and will generate over $8.3 billion revenue by 2018 The leading company in mobile security analysis, Goode Intelligence, has published a new market forecast report covering the mobile biometric security market which, driven by Apple's positive move with Touch ID, forecasts exceptional growth for the industry. full article http://www.investorideas.com/news/2013/biometrics/10281.asp Research Biometric stocks at Investorideas.com stock directory http://www.investorideas.com/BPS/Stock_List.asp

Aethlon Medical (OTCBB: AEMD) Gains 14.17% Following Note Authored by Chairman and CEO, Jim Joyce; Cancer Immunotherapy Article, Introduction to Dr. Douglas Taylor

New York, NY, Point Roberts, WA - October 25, 2013 (Investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research for independent investors reports on trading for medical technology stock Aethlon Medical, Inc. (OTCBB :AEMD), closing at $0.1450, gaining $ 0.0180 or 14.17% as of the close Oct 24 th, on volume of 878,373 shares.

Yesterday the Company issued a note authored by Chairman and CEO, Jim Joyce. The stock traded higher than normal volume and had a high of $0.1470.
Excerpt:
Last week, the Wall Street Journal published an informative article on the emergence of cancer immunotherapies designed to augment the immune system's ability to recognize and combat malignant tumors. The oncology community is embracing this new treatment paradigm based on mounting clinical evidence that immunotherapies can produce long-term responses across multiple tumor types when combined with traditional therapies. As per the article, industry analysts project that immunotherapies could represent half of all cancer treatments within the next 10 years. The opportunity in lung cancer alone was referenced as a $6 billion opportunity.
At least five major drug companies are advancing candidates, including Bristol-Myers Squibb, whose drug Yervoy is already approved for melanoma. Drug mechanisms that inhibit the PD-1 molecular pathway, which cancer cells hijack to evade destruction by the body's immune system, are a primary target in the emerging immunotherapy pipeline. The article also balanced the compelling promise of these candidates with the reality that PD-1 inhibitors and other immunotherapies face significant administration and cost hurdles. Much of the concern is associated with the challenge of stacking an immunotherapeutic drug on top of the toxicity of established therapies such as radiation, chemotherapy, targeted cancer agents or other PD-1 inhibitors. Beyond this challenge, the cost of combining such therapies could prove to be prohibitive considering that Yervoy alone costs $120,000 for four doses administered over 12 weeks.
From an Aethlon Medical perspective, the Wall Street Journal article serves to reinforce our vision that a medical device can deliver immunotherapeutic benefit to both established and candidate cancer therapies, and do so economically and without added drug toxicity.
Full news:http://www.investorideas.com/CO/AEMD/news/2013/10241.asp
About Aethlon Medical
Aethlon Medical creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of devices the rapid, yet selective removal of disease promoting particles from the entire circulatory system. At present, The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer, and a medical device being developed under a 5-year contract with Defense Advanced Research Projects Agency (DARPA) to reduce the incidence of sepsis in combat-injured soldiers. For more information, please visit www.aethlonmedical.com.
About InvestorIdeas.com:
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense renewable energy, food and beverage stocks and others.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for our news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and use our 14 online stock directories to research stocks - waters stocks, renewable energy, tech, mobile, mining stocks and more… http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Disclosure: Investorideas has been compensated by AEMD for news distribution and content publishing: three thousand per month effective June 2013
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
800-665-0411 - Source - www.Investorideas.com

Mining Stock Alert: DNA Precious Metals Inc. (OCTQB: DNAP) to be Presenting at the 2013 Silver Summit Conference Today

Montreal, Canada - October 24, 2013 (Investorideas.com Mining stocks newswire) DNA Precious Metals Inc. ("DNA" or "the Company") (OCTQB:DNAP) has been invited to speak at the 2013 Silver Summit conference in Spokane, Washington on Thursday, October 24, 2013 at 1:50pm am, Pacific time. The Silver Summit conference is a world premier event of among others, mining company executives and institutional investors, sponsored yearly by Cambridge House International. DNA Precious Metals is honored to participate in this important high-level conference where the Company will be presenting an update on its Montauban tailings mine production target of Q2 2014, and the acquisition of the Montauban gold silver zinc lead past producer, as well as strategy, results and upcoming plans.

CONFERENCE DETAILS
When: October 24 - 25 at
Where: The Davenport Hotel, Spokane, WA.
Online: http://www.cambridgehouse.com/node/13049
Ronald Mann, President and CEO states; "Participating companies are pioneers for having the vision to see that conferences bring together the brightest investing minds from around the world. If they have this kind of vision when it comes to meeting investors, you should come hear their vision for the future of their own companies."
About DNA Precious Metals, Inc.
DNA Precious Metals, Inc. is focused on near term production of the Montauban tailings mine in the Province of Quebec, Canada with an aggressive search for economic production assets. The company trades on the OTCQB market in the United States under the stock symbol DNAP. For more information, please go to   www.DNAPreciousMetals.com .
On behalf of the Board
Ronald K. Mann, CEO
Forward Looking Disclaimer
This release contains forward-looking statements that involve risks and uncertainties. Readers are referred to the Securities and Exchange Commission filings filed by the Company on EDGAR at www.sec.gov/edgar.shtml, specifically the most recent reports which identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements. The Company undertakes no obligation to review or confirm analysts' expectations or estimates or to publicly release any revisions to any forward-looking statements. The information contained in this press release should not be construed as any indication of the Company's future stock price, its revenues or results of operations.
CONTACT INFORMATION
Ronald Mann, CEO
DNA Precious Metals Inc.
ronald.mann1@dnapreciousmetals.com
Twitter: www.twitter/dnametals
Facebook: www.facebook.com/dnametals
INVESTOR RELATIONS
Stuart T. Smith, CEO
SmallCapVoice.Com, Inc.
ssmith@smallcapvoice.com
Tel: +1-(512)-267-2430
Skype: SmallCapVoice.com
Disclaimer/ Disclosure:The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Investorideas is compensated by DNAP for news and content publication and syndication ( October 2013 - five thousand for one month of news distribution on Investor ideas news wire ) More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Medical Technology Breaking News: Aethlon Medical (OTCQB: AEMD) Note: Cancer Immunotherapy Article, Introduction to Dr. Douglas Taylor

SAN DIEGO - October 24, 2013 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce.

Last week, the Wall Street Journal published an informative article on the emergence of cancer immunotherapies designed to augment the immune system's ability to recognize and combat malignant tumors.  The oncology community is embracing this new treatment paradigm based on mounting clinical evidence that immunotherapies can produce long-term responses across multiple tumor types when combined with traditional therapies.  As per the article, industry analysts project that immunotherapies could represent half of all cancer treatments within the next 10 years. The opportunity in lung cancer alone was referenced as a $6 billion opportunity. 
At least five major drug companies are advancing candidates, including Bristol-Myers Squibb, whose drug Yervoy is already approved for melanoma.  Drug mechanisms that inhibit the PD-1 molecular pathway, which cancer cells hijack to evade destruction by the body's immune system, are a primary target in the emerging immunotherapy pipeline. The article also balanced the compelling promise of these candidates with the reality that PD-1 inhibitors and other immunotherapies face significant administration and cost hurdles. Much of the concern is associated with the challenge of stacking an immunotherapeutic drug on top of the toxicity of established therapies such as radiation, chemotherapy, targeted cancer agents or other PD-1 inhibitors.  Beyond this challenge, the cost of combining such therapies could prove to be prohibitive considering that Yervoy alone costs $120,000 for four doses administered over 12 weeks.
From an Aethlon Medical perspective, the Wall Street Journal article serves to reinforce our vision that a medical device can deliver immunotherapeutic benefit to both established and candidate cancer therapies, and do so economically and without added drug toxicity.
Our device strategy targets a survival mechanism deployed by tumors to evade and defeat the immune system of cancer patients.  This mechanism, which is not addressed by drug therapies, is the seretion of exosomes by cancerous tumors.  Researchers have discovered that tumors release these particles to trigger the death of cancer fighting immune cells and facilitate the spread of metastasis.  Additionally, the systemic elimination of exosomes may represent a novel strategy to inhibit the PD-1 molecular pathway.  To date, researchers have demonstrated that the Aethlon Hemopurifier® can capture exosomes underlying lymphoma, melanoma, ovarian, and breast cancer. If you are not familiar with the Hemopurifier®, it is a first-in-class medical device that targets the rapid elimination of life-threatening infectious viruses and tumor-secreted exosomes from circulation.  
Based on the recent approval (after 5+ years of effort) of an investigational device exemption (IDE) by FDA, we are preparing to initiate the first U.S. studies of Hemopurifier® therapy in Hepatitis-C (HCV) infected individuals. In studies previously conducted overseas, Hemopurifier® therapy was demonstrated to accelerate viral load depletion in hardest-to-treat HCV patients receiving standard-of-care drug therapy.
As a result of crossing the IDE approval threshold, we opened the door to advance relationships with medical institutes that have clinical interest in expanding Hemopurifier® indications to include various forms of cancer.
When we initiated our first cancer research activities, we were making two intuitive yet forward-looking bets.  The first was that exosomes would emerge to become a vital therapeutic target.  The second was a belief that novel immunotherapies would rethink the landscape for treating cancer.  Today, tumor-secreted exosomes are well-documented therapeutic targets and cancer immunotherapies are expected to take center stage in the cancer treatment arena. There is growing hope that the marriage of traditional cancer therapies with next-generation immunotherapies may someday allow cancer to become a manageable condition much like HIV-infection is managed through a cocktail of treatment mechanisms.  At Aethlon Medical, our role is to provide the oncology community with a therapeutic tool that counters the immunosuppressive impact of exosomes without adding drug toxicity to companion cancer therapies.  
In closing, I am providing the scientific viewpoint of Dr. Douglas Taylor on the potential implications of Hemopurifier® therapy in cancer care.  Dr. Taylor is credited with the discovery of tumor-secreted exosomes and is a leading published author on the topic.  He is also one of the newest members of the Aethlon family as he has accepted the position of Chief Scientific Officer at our Exosome Sciences diagnostic subsidiary. The following is a statement from Dr. Taylor:
Evidence indicates that molecules, such as programmed cell death-1 (PD-1) and CTLA-4, are exploited by tumors to suppress patient immune surveillance, allowing the progression of cancers. These molecules and their ligands negatively regulate anti-tumor immune responses, particularly CD8+ effector T cells. Treatment of activated T cells with anti-PD-L1 antibodies reduce T cell proliferation, which correlates with attenuated IL-2 secretion. In vitro cytotoxicity studies and in vivo growth inhibition can be restored utilizing anti-PD-L1 antibodies or by genetic silencing of PD-1.  The expression of PD-L1 on tumor cells inhibits anti-tumor immunity through engagement of PD-1 on effector T cells. Expression of PD-L1 on tumors is correlated with reduced survival in many tumor types.
Due to the role of these molecules in immune regulation and correlation with cancer outcomes, these pathways are being targeted for immunotherapy. Bristol Myers' experimental PD-1 inhibitor Nivolumab and Merck's candidate, MK-3475, block the PD-1/PD-L1 interaction, allowing the immune system to react with the tumor cells. Yervoy targets a similar checkpoint, inhibiting the CTLA-4 pathway. Unlike genetically targeted drugs, which disrupt mutations that fuel tumor growth, the new agents treat the immune system. Current interest in targeting these molecular pathways raises a concern that their normal function acts as to modulate the immune system to prevent attacks on healthy cells. Studies in murine models deficient for PD-1 developed dilated cardiomyopathy and congestive heart failure and that expression of PD-1 may also prevent autoimmune diseases. Based on the critical role of PD-1 and CTLA-4, targeting their expression may be problematic resulting in serious side effects on the host. However, an essential component of the activity of such molecules may be due to their presence on exosomes released by tumor cells. We previously demonstrated the presence of these immunoregulatory molecules on tumor-derived exosomes and their ability to suppress T cell activation and proliferation ( Taylor et al. Clinical Cancer Research , 9: 5113-5119, 2003). Thus, a reasonable approach that does not result in systemic toxicity would be the removal of these immunoregulatory molecules. Consequently, the ability of the Hemopurifier® to remove these circulating exosomes may provide a superior approach to treat these patients without the generalized inhibition of the respective molecular pathways. About Aethlon Medical
Aethlon Medical creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of devices the rapid, yet selective removal of disease promoting particles from the entire circulatory system. At present, The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer, and a medical device being developed under a 5-year contract with Defense Advanced Research Projects Agency (DARPA) to reduce the incidence of sepsis in combat-injured soldiers. For more information, please visit www.aethlonmedical.com.
Certain statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, that the company can successfully protect its intellectual property, that removal of exosomes from the human body will impact or lead to successful treatment of cancer, or that exosomes are the cause of tumor growth and progression, that the FDA will not approve the initiation of the Company's clinical programs or provide market clearance of the company's products, future human studies whether revenue or non-revenue generating of the Aethlon ADAPT™ system or the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer or hepatitis C therapies or as a standalone cancer or hepatitis C therapy, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Contacts:
James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
Marc Robins
877.276.2467
mr@aethlonmedical.com
Published at Investorideas.com newswire
Sign up for the free investor news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. Disclosure: Investorideas has been compensated by AEMD for news distribution and content publishing: three thousand per month effective June 2013
http://www.investorideas.com/About/Disclaimer.asp
This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar

Mining Stock Alert: DNA Precious Metals Inc. (OCTQB: DNAP) Announces it has Signed a Binding Agreement to Acquire Additional Mining Interest on the Montauban Mine Property

Montreal, Canada - October 22, 2013 (Investorideas.com Mining stocks newswire) DNA Precious Metals Inc. ("DNA" or "the Company") (OCTQB:DNAP) is pleased to announce that it has signed a Binding Agreement with Excel Gold Mining Inc. for an undivided one hundred (100%) interest for all of their Montauban Mine Property assets located in Notre-Dame-de-Montauban, Quebec, Canada. The 5 contiguous claims ("Mineral Claims") consist of a mining lease and a mining concession totalizing an approximate surface of 76.84 hectares. These 5 mining claims are contingent to DNA's mining claims covering an area of approximately 340 hectares on the Montauban Mine Property, and are described as Les Mines de Montauban in the Property Map on the DNA Website http://www.dnapreciousmetals.com/maps.

DNA Precious Metals Inc. has fulfilled its contractual obligations under the Agreement and paid "In Trust" for the benefit of the Vendor funds and common shares of DNA Precious Metals Inc. representing a value of over $600,000 as of the date of this Release.
The acquired mining assets, described as Les Mines de Montauban on the Property Map http://www.dnapreciousmetals.com/maps , are fundamental to DNA's currently 100% claimed Montauban Mine Property mining claims. This acquisition solidifies DNA Precious Metal's Montauban Mine Property bundle, while expanding exploration and mining potential and enhancing access. More importantly, the added value of this acquisition resides in the granted mining lease and underground rights that accompany the newly acquired mining claims.
Reported Historical Past production from Les Mines de Montauban includes 132,000 oz gold, and 4,300,000 oz silver as well as 77,000 tons zinc, 24,000 tons lead.
"This acquisition is in line with the Company's objective of low capital cost production targets, while positioning the Company for continued growth with the Montauban Mine Project. Procuring these claims will significantly increase the Company's long term exploration program, enhancing the investment in these prospective claims" said Ronald Mann, President and CEO of DNA Precious Metals Inc.
Newly Acquired Mineral Claims
The newly acquired Minerals Claims include three shafts, extensive underground workings and includes the "Golden Goose" north strike area of the Montauban mineralized near surface ore belt, one of the many significant highlights of the acquired property. This mineralized ore block, with Historical Resources non 43-101, Mirabel Resources, consists of approximately 693, 590 metric tons grading an average 3.44 g/t Au and 14.32 g/t Ag. http://www.dnapreciousmetals.com/maps
The vendor intercepted significant results in their 2009 drill campaign on the acquired property. Selected assay highlights of gold/silver intercepts, historical drilling, non 43-101, non Canadian drilling reporting standard compliant, on the newly acquired Montauban Mine Property include an intercept over 9 metres at a depth of less than 20 metres of 4.10 g/t Au and 19.49 g/t Ag. See table below.
MONTAUBAN 2009 DRILLING RESULTS
DDH From To Interval Au Ag
No (m) (m) (m) (g/t) (g/t)
EM-09-01 13.00 17.30 4.30 4.82 19.03
EM-09-15 0.50 5.00 4.50 2.15 15.11
EM-09-17 1.50 5.00 3.50 3.43 17.34
EM-09-21 1.50 4.50 3.00 8.96 18.94
EM-09-23 1.50 10.00 8.50 2.54 19.69
EM-09-26 1.50 6.00 5.00 1.41 10.62
EM-09-27 1.50 10.00 8.50 7.34 17.02
EM-09-28 3.00 5.58 2.58 14.32 25.84
EM-09-29 3.15 9.00 5.85 2.92 11.69
EM-09-35 7.40 12.50 5.10 6.77 24.29
EM-09-38 5.50 13.50 8.00 3.13 13.70
including 12.50 13.50 1.00 10.90 46.70
EM-09-40 10.50 19.50 9.00 4.10 16.49
including 18.50 19.50 1.00 20.80 33.70
EM-09-41 12.50 19.50 7.00 2.07 6.43
EM-09-45 8.00 10.00 2.00 7.16 0.90
EM-09-47 3.50 5.50 2.00 3.24 6.85
EM-09-56 15.00 22.00 7.00 4.49 12.37
EM-0958 17.00 25.00 8.00 3.78 28.26
including 17.00 18.00 1.00 11.75 65.30
About DNA Precious Metals, Inc.
DNA Precious Metals, Inc. is focused on near term production of the Montauban tailings mine in the Province of Quebec, Canada with an aggressive search for economic production assets. The company trades on the OTCQB market in the United States under the stock symbol DNAP. For more information, please go to   www.DNAPreciousMetals.com .
On behalf of the Board
Ronald K. Mann, CEO
Forward Looking Disclaimer
This release contains forward-looking statements that involve risks and uncertainties. Readers are referred to the Securities and Exchange Commission filings filed by the Company on EDGAR at www.sec.gov/edgar.shtml, specifically the most recent reports which identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements. The Company undertakes no obligation to review or confirm analysts' expectations or estimates or to publicly release any revisions to any forward-looking statements. The information contained in this press release should not be construed as any indication of the Company's future stock price, its revenues or results of operations.
CONTACT INFORMATION
Ronald Mann, CEO
DNA Precious Metals Inc.
ronald.mann1@dnapreciousmetals.com
Twitter: www.twitter/dnametals
Facebook: www.facebook.com/dnametals
INVESTOR RELATIONS
Stuart T. Smith, CEO
SmallCapVoice.Com, Inc.
ssmith@smallcapvoice.com
Tel: +1-(512)-267-2430
Skype: SmallCapVoice.com
Disclaimer/ Disclosure:The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Investorideas is compensated by DNAP for news and content publication and syndication ( October 2013 - five thousand for one month of news distribution on Investor ideas news wire ) More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Market Experts to Speak at The PIPEs Conference?

Woodbury, NY - October 21, 2013 (www.investorideas.com newswire) The PIPEs Conference has been the most important and influential event in the Small Cap deal market for the past 10 years. This year the event will be held at The Westin Times Square in New York on November 4th.

This year's event will feature all of the topics of importance to professionals in the small-cap equity market, covering much more than just direct investments and PIPEs. The agenda features sessions on reverse mergers and SPACs, stock trading issues, legal issues, and the latest funding structures. Ample time will also be given to discuss how technology is changing the market, including the migration from traditional brokerage businesses to online funding portals, and what the new regulatory landscape means for issuers, investors, and intermediaries.
Agenda highlights include:

• The Recent Resurgence of PIPE Deals: Who's Transacting, Under What Terms, and a Discussion on Sustainability – Featuring Ele Klein from Schulte Roth & Zabel; Joshua Silverman from Iroquois Capital Management; and Richard Gormley from Lazard
• General Solicitation, Third Party Investor Verification and Advertising: The Latest in Online Deal Marketing, Fund Marketing, and Regulation D Requirements – Featuring Peter Lehrman from Axial; Barry Silbert from SecondMarket; and David Pankey from McGuire Woods
• Equity Crowdfunding: Progress on SEC Rulemaking, State's Securities Boards and Discussions on Fraud and Other Concerns – Featuring Tim Sullivan from Microventure Marketplace; and Loren Heger from FNEX and
• The JOBS Act and Its Broader Effect on Capital Markets Activity – Featuring John Borer from Benchmark Capital
• Reverse Mergers & Smaller IPOs: New Deal Structures to Avoid Shell Status, Examining the Recent Crop of Companies and what's made some of them Successful – Featuring David Bukzin from Marcum; Cromwell Coulson from OTC Markets and Noemi Schmayer from M. Firon & Co.

Over 350 attendees are expected to attend the event comprised of institutional investors, investment bankers, structured finance investors, hedge fund managers, deal advisors, IR professionals, attorneys, accountants and public and private company management teams.
For information about the event visit: http://www.dealflowevents.com/conferences/pipes_conference_2013/.
About DealFlow Events
Since its inception in 2002, DealFlow Events has hosted over 200 conferences covering alternative asset markets. DealFlow events are the signature programs in their respective markets, bringing together the leading practitioners in each field with major sponsors servicing the market. DealFlow events are seen as opportunities for education in addition to networking with colleagues. The tag line "A DealFlow Event," carries clout, which is why it's always included in the event branding. Program managers develop each program by vetting the major issues and trends surfacing over the course of the year. At all times, the focus is on providing attendees with the highest quality content possible. The program always comes first.
For information or to learn more about DealFlow Events, please contact us.
DealFlow Events
131 Jericho Tpke. PH3
Jericho, NY 11753
Phone (516) 876-8006
www.dealflowevents.com

Mining Stock Alert: SilverCrest (TSX.V: SVL) (NYSE MKT: SVLC) Announces Positive La Joya Preliminary Economic Assessment Base Case Pre-Tax NPV(5%) of US$133 Million and 30% IRR for "Starter Pit"

Vancouver, British Columbia - October 21, 2013 (Investorideas.com Mining Stocks Newswire) SilverCrest Mines Inc. (TSX.V:SVL) ( NYSE MKT: SVLC) ("SilverCrest" or the "Company") is pleased to announce that it has completed the Preliminary Economic Assessment ("PEA") for its La Joya Silver Copper Gold Project ("La Joya") located in Durango, Mexico. Summaries of the current resources used for the PEA, a preliminary Life of Mine Plan (LOMP), operating costs, capital costs and project economics are presented in tables below. A Technical Report compliant with NI 43-101 is being completed by EBA Engineering Consultants, a Tetra Tech Company (EBA) with an effective date of September 23, 2013 to be filed within 45 days of this release. All currency values are presented in US$ unless otherwise specified.

N. Eric Fier, President & COO stated, "The positive results of this PEA will enable us to plan the next steps, establish achievable milestones and identify additional studies and analyses to optimize the project economics. We have engaged extensively with local communities at this early stage of the La Joya project development, emphasizing the importance of building collaborative, long term and sustainable relationships with all stakeholders."
The PEA focuses on the first stage of La Joya development ("Starter Pit") as a low strip, open pit with an initial 9 year life of mine plan ("LOMP") and opportunities for expansion. This approach provides attractive economic returns using conservative metal price estimates and lower initial capital costs, which are more attractive in the current market. The conceptual open pit operation would be in conjunction with a 5,000 tonnes per day (tpd) conventional mill and flotation/leaching plant to produce a high grade silver-copper concentrate with gold credits. The Starter Pit will have a conceptual average annual production of 3.9 million silver equivalent (AgEQ)* ounces per year and approximately 5 million ounces AgEQ* per year for each of the first 4 years of operation. An expansion of the Starter Pit to include additional resources within a larger pit would then be contemplated.
The Company cautions that the PEA is preliminary in nature in that it is based on Inferred Mineral Resources which are considered too speculative geologically to have the economic considerations applied to them that would enable them to be characterized as mineral reserves, and there is no certainty that the PEA will be realized. Mineral resources that are not mineral reserves do not have demonstrated economic viability.
HIGHLIGHTS OF THE PRELIMINARY ECONOMIC ASSESSMENT
The PEA incorporated Base Case metal prices of $22/oz Ag, $3/lb Cu and $1200/oz Au (5 year historical average). Highlights of the Base Case economic estimates for the Starter Pit are as follows:

• Pre-tax NPV5% of $133 million and an Internal Rate of Return ("IRR") of 30.5%
• Pre-tax NPV5% of $156 million and IRR of 34% using current metal prices of $21.93/oz Ag, $1316.25/oz Au and $3.27/lb Cu (as of 18/10/2013)
• After-tax NPV5% of $93 million and an IRR of 22%
• Payback period of approximately 2 years on initial capital
• Pre- production capital costs of $141 million including contingencies of $17 million
• Sustaining capital is estimated at $8 Million
• Cash operating costs for the first three years average $10 per ounce AgEQ* and $13 per ounce AgEq* for the 9 years Starter Pit
• Pre-tax undiscounted operating cash flow before capital expenditures totalling $342.5 million at an average of $38 million per year with the first four years averaging $60 million per year
• A 9 year LOMP with 15.5M tonnes grading 50g/t Ag, 0.33%Cu and 0.19 g/t Au
• Life of mine production of an estimated 34.8 million payable AgEQ*ounces, consisting of 19 million ounces of silver and 53 thousand ounces of gold and 93 million pounds of copper in concentrate, and
• Production of an attractive high grade silver-copper concentrate (averaging 35% Cu and 4kg/t Ag) with a gold by- product.

* Silver equivalency for the PEA includes silver, gold and copper and excludes lead, zinc, molybdenum and tungsten values. The Price Ratio for Ag:oz Au is (54.4:1), lb Cu:oz Ag is (7.3:1), both based on 5 year historic metal price trends of US$22/oz silver, US$1200/oz gold, US$3/lbs. copper. Metallurgical recoveries are incorporated in the economic analysis (see Summary of PEA parameters in table below).
* Silver equivalency for the PEA includes silver, gold and copper and excludes lead, zinc, molybdenum and tungsten values. Price ratio for Ag: Au is (54.4:1), Ag:Cu is (7.3:1), both based on 5 year historic metal price trends of US$22/oz silver, US$1200/oz gold, US$3/lbs. copper. Metallurgical recovery is incorporated as recoverable metal.
The PEA for the Starter Pit reports strong revenues in the initial four years of operations and a decrease in the revenues for subsequent two years due to decrease in the grades. It is anticipated that additional drilling and optimization of the mine schedule could improve these results based on the presence of high grade material in some sectors of the deposit which may ultimately be incorporated into the mine plan.
Sensitivity analyses were completed by adjusting commodity prices, the results of which are presented in the following graph.
To view the graph, please click on the following link: http://media3.marketwire.com/docs/svl1021-Graph.pdf.
The Starter Pit economics are more sensitive to silver and copper price, as they represent 55% and 36% of the total revenues respectively under the base case scenario. Each 10% increment in metal prices from the base case changes the pre-tax NPV by approximately $60 million and the IRR by approximately 8%.
PEA CAPITAL COSTS
EBA completed detailed cost estimates for the mine and processing plant based on preliminary vendor quotes, contract mining and similar projects recently completed in Mexico. Pre-production capital costs are estimated to total US$141 million including a $17 million contingency using an open pit mine contractor. This includes development of the project over a period of 1.5 years including initial mining for one year before start-up of operations. The La Joya property has excellent infrastructure to keep capital costs reasonable with a nearby international airport, highways, railway, main power grid and lines, several operating mines and communities with available workforce. The pre-production capital costs from the PEA are summarized below.
Provisions for $8 million of working capital and $6 million in mine closure have been made as part of the economic analyses in the PEA.
PEA STUDY PARAMETERS
The PEA has incorporated the following operational and economic parameters used in the Net Smelter Return Model ("NSR") for the silver-copper-gold concentrate and also gold-silver dore production model from tailings leaching.
No smelter penalty charges for deleterious metals were applied to the concentrate for the PEA. The study assumes that silver copper concentrate will be shipped overseas by trucking from site to a port in Mexico which is the most used route for concentrate producers in operation near La Joya.
PROCESSING & METALLURGY
The most recent metallurgical studies indicate that a conventional flotation circuit will potentially recover a high grade silver copper concentrate with gold credits. Depending on mineralization style and conditioning applied on the ALS locked cycle flotation tests, preliminary metal recoveries to the third cleaner concentrates range from 82.7 to 86.7% Cu, 76.7 to 84.3% Ag, and 18.2 to 42.4% Au for Manto and Structure composites. A gold leaching circuit with potential to recover 90% of gold and silver from the tailings to produce metal dore has also been incorporated in the PEA.
The bulk silver copper concentrates from preliminary results produced from Manto and Structure composites show certain potentially deleterious elements for smelting such as arsenic, antimony and bismuth. Adding cyanide at cleaner flotation stages reduces the arsenic content to acceptable market limits without sacrificing copper, silver and gold recoveries. Additional test work is in progress to assess the distribution, concentration and potential reduction of antimony and bismuth.
LA JOYA RESOURCES
The La Joya mineral deposit is defined as a silver copper-gold skarn with disseminated to semi-massive sulphide (bornite - chalcopyrite) with three main ore types; Mantos, Structures and Contact Zone. The updated Mineral Resource estimations for the La Joya Project provided estimated Inferred Resources of 126.7 million tonnes grading 23.5 gpt Ag, 0.19%Cu and 0.17 gpt Au containing 198.6 million ounces of silver, 533 million pounds of copper and 95,900 ounces of gold. These resource estimates were announced by news release dated January 29, 2013 and are contained in a technical report dated March 27, 2013 titled "Updated Resource Estimate for the La Joya Property, Durango, Mexico" and are the basis for the PEA.
* Silver equivalency for the resource estimation filed on March 27th, 2013 includes silver, gold and copper and excludes lead, zinc, molybdenum and tungsten values. Ag:Au is 50:1, Ag:Cu is 86:1, based on 5 year historic metal price trends ofUS$24/oz silver, US$1200/oz gold, US$3/lb copper. 100% metallurgical recovery is assumed. Classified by EBA, a Tetra Tech Company and conforms to NI 43-101 and CIM definitions for resources. All numbers are rounded. Inferred Resources have been estimated from geological evidence and limited sampling and must be treated with a lower level of confidence than Measured and Indicated Resources. Note that AgEQ calculation for resources is different than PEA economic analysis based on change in metal prices. Mineralization boundaries used in the interpretation of the geological model and resource estimate are based on a cut-off grade of 15 g/t AgEq using the metal price ratios described above.
The conceptual first stage for development of La Joya with an initial 9 year Starter Pit uses the 60g/t Ag Eq cut off Inferred Resource for Manto and Structure Zones representing mineralized zones close to the surface. The PEA conceptual open pit and economic analysis excludes the Contact Zone, Santo Nino and Cerro Coloradito resources which are included in the above table.
The Contact Zone resources, not incorporated in the PEA, contains consistent Tungsten mineralization which is currently the subject of additional studies aimed at definition of preliminary economic parameters to be integrated in future assessment of the La Joya Project.
PEA POTENTIAL PRODUCTION
The Whittle Pit analysis examined the NPV of 41 potential pits utilizing a 5,000 tpd operational capacity. The optimum pit is #31 with the highest NPV(see Table below) producing a 15.8 years LOMP, but it did not meet the criteria established for a Starter Pit with low strip ratio (less than 3:1) and reasonable capital costs. On this basis the selected pit for mine design & scheduling was Pit # 18.
* 41 Optimized pit shells have been generated by keeping the parameters used for the Whittle optimization constant (Operating Costs, Metallurgical Recoveries, Pit Slope Angles and Discount Factor) and by varying the Revenue using a range of metal prices illustrated in the table above.
The optimal mine scheduling incorporates, mining ore and waste in the year-1 grade optimization and stockpiling of material for reprocessing during the project life. is The production scheduling (Mill Feed Tonnes & grades) is illustrated as follows:
The 5,000 tpd processing plant will be comprised of crushing, milling and standard flotation facilities with production of a silver-copper concentrate as well as a gold-silver leaching circuit for re-treatment of tailings. The PEA adopted as a guideline a mitigation of environmental and social impact by minimizing the footprint of all proposed operational facilities in the region.
PEA OPPORTUNITIES AND FUTURE STUDIES
Several opportunities are identified that could significantly enhance the economic return outlined in the PEA, including the following:

• The current Inferred Resources at La Joya provide opportunity for significant project expansion,
• Mineralization at La Joya is open in most directions with excellent potential to further increased resources. Further infill and expansion drilling is recommended to reclassify resources at a Pre-Feasibility Study level,
• Additional and detailed metallurgical test work will be completed aiming to optimize the metallurgical flow sheet and potentially improve metal recoveries,
• Review and optimization of the mining schedule could potentially provide opportunities for reduction in waste and haulage costs which could decrease capital and operating mining costs,
• This PEA does not address the potential for recovery of several other identified potential products including tungsten, molybdenum, lead, zinc, and tin which may have significant value. Further work is recommended, and
• Several other targets have been identified on the plus 10,000 hectare concession that remain to be explored for potential new discoveries.

The Qualified Persons for this Technical Report and who have reviewed and approved the contents of this news release are Mark Horan, M.Sc., P.Eng., James Barr, P.Geo., Scott Martin, P.Eng. and Graham Wilkins, P.Eng. from the consulting firm of EBA, a Tetra Tech Company, and Ting Lu, M.Sc., P.Eng., Hassan Ghaffari, MASc., P.Eng., Sabry Abdel-Hafez, PhD., P.Eng. and Nick Michael from Tetra Tech. The Technical Report for the PEA will be filed on SEDAR with 45 days of this release.
SilverCrest Mines Inc. (TSX VENTURE:SVL)(NYSE MKT:SVLC) is a Canadian precious metals producer headquartered in Vancouver, BC. SilverCrest's flagship property is the 100%-owned Santa Elena Mine, located 150 km northeast of Hermosillo, near Banamichi in the State of Sonora, México. The mine is a high-grade, epithermal silver and gold producer, with an estimated life of mine cash cost of US$8 per ounce of silver equivalent (55:1 Ag: Au). SilverCrest anticipates that the 2,500 tonnes per day open pit heap leach facility at the Santa Elena mine should recover approximately 625,000 ounces of silver and 33,000 ounces of gold in 2013. Major expansion and construction of a 3000 tonnes per day conventional mill facility is underway to significantly increase metals production at the Santa Elena Mine (open pit and underground) by 2014. Exploration programs continue to make new discoveries at Santa Elena and also have rapidly advanced the definition of a large polymetallic deposit at the La Joya property in Durango State with stated resources nearing 200 million ounces of Ag equivalent.
FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking statements" within the meaning of Canadian securities legislation and the United States Securities Litigation Reform Act of 1995. Such forward-looking statements concern the Company's anticipated results and developments in the Company's operations in future periods, planned exploration and development of its properties, plans related to its business and other matters that may occur in the future. These statements relate to analyses and other information that are based on expectations of future performance, including silver and gold production and planned work programs. Statements concerning reserves and mineral resource estimates may also constitute forward-looking statements to the extent that they involve estimates of the mineralization that will be encountered if the property is developed and, in the case of mineral reserves, such statements reflect the conclusion based on certain assumptions that the mineral deposit can be economically exploited.
Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking statements, including, without limitation: risks related to precious and base metal price fluctuations; risks related to fluctuations in the currency markets (particularly the Mexican peso, Canadian dollar and United States dollar); risks related to the inherently dangerous activity of mining, including conditions or events beyond our control, and operating or technical difficulties in mineral exploration, development and mining activities; uncertainty in the Company's ability to raise financing and fund the exploration and development of its mineral properties; uncertainty as to actual capital costs, operating costs, production and economic returns, and uncertainty that development activities will result in profitable mining operations; risks related to reserves and mineral resource figures being estimates based on interpretations and assumptions which may result in less mineral production under actual conditions than is currently estimated and to diminishing quantities or grades of mineral reserves as properties are mined; risks related to governmental regulations and obtaining necessary licenses and permits; risks related to the business being subject to environmental laws and regulations which may increase costs of doing business and restrict our operations; risks related to mineral properties being subject to prior unregistered agreements, transfers, or claims and other defects in title; risks relating to inadequate insurance or inability to obtain insurance; risks related to potential litigation; risks related to the global economy; risks related to the Company's status as a foreign private issuer in the United States; risks related to all of the Company's properties being located in Mexico and El Salvador, including political, economic, social and regulatory instability; and risks related to officers and directors becoming associated with other natural resource companies which may give rise to conflicts of interests. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in the forward-looking statements. The Company's forward-looking statements are based on beliefs, expectations and opinions of management on the date the statements are made. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.
The information provided in this news release is not intended to be a comprehensive review of all matters and developments concerning the Company. It should be read in conjunction with all other disclosure documents of the Company. The information contained herein is not a substitute for detailed investigation or analysis. No securities commission or regulatory authority has reviewed the accuracy or adequacy of the information presented.
N. Eric Fier
N. Eric Fier, President and COO
SILVERCREST MINES INC.
Contact:
SilverCrest Mines Inc.
Fred Cooper
(604) 694-1730 ext. 108
Toll Free: 1-866-691-1730
(604) 694-1761
info@silvercrestmines.com
www.silvercrestmines.com
Neither TSX Venture Exchange nor its Regulation Services Provider (as defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Published at Investorideas.com Newswire
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: SilverCrest Mines has compensated Investorideas.com for the distribution and publishing of this news release (annual news publication 9700) http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894